Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
With the same doses of semaglutide, there was a resulting 2.1%, 0%, 0%, 2.5%, 4.7%, and 9.1% respective increases in the proportion of patients achieving a 10%, or greater, reduction in weight loss
These findings support and extend the evidence from clinical trials, demonstrating that the superior weight reduction efficacy of tirzepatide is evident in routine clinical practice
Patients with diabetes require glucose monitoring to adjust concurrent diabetes medications and prevent hypoglycemia
Key Takeaways GLP-1 medications have the strongest weight-loss evidence for overall body-weight reduction
This dose produces significant results for most people
Who cannot use Wegovy
US$ 21.71
US$ 25.26
US$ 21.16
US$ 20.36
US$ 23.40
US$ 20.53
US$ 26.00
